Year: 2011
Type: review
Abstract: A PPROXIMATELY 300,000 patients undergo cardiac surgical procedures each year in the United States.More than 80% of routine cardiac surgical procedures are performed using cardiopulmonary bypass (CPB). 1 Acute kidney injury (AKI; previously referred to as acute renal failure) after CPB is a well-known, yet incompletely understood, entity that has significant implications on both short-and long-term outcomes.The development of AKI after CPB is associated with a significant increase in infectious complications, an increase in length of hospital stay, and greater mortality when compared with patients without AKI-CPB.2 The incidence of AKI-CPB averages 20 -30%, depending on the definition used and the duration of the postoperative period studied.3,4 Furthermore, more patients with AKI-CPB who require dialysis remain dialysis dependant.For all patients undergoing CPB, the risk of AKI-CPB is the least in those who undergo coronary artery bypass grafting (CABG) only; the risk increases for patients undergoing valve replacement surgery; and the risk is the greatest after combined CABGvalve procedures.4 There has not been a significant reduction in mortality, despite many recent advances in our understanding of the causative pathophysiology and pharmacotherapeutics of AKI-CPB.Furthermore, advances in renal replacement therapies (RRTs) have not significantly altered the overall mortality associated with AKI-CPB.In this review, we will focus on the current definitions of AKI, pathophysiologic features, and risk factors for develop-ing AKI-CPB.We will also discuss perioperative strategies and emerging concepts that add to our understanding of this complex entity to help better manage patients at risk for AKI-CPB.
Source: Anesthesiology
Authors: Avinash B. Kumar, Manish Suneja, Bruno Riou
Language: English
Topic: Acute Kidney Injury Research
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2013873227
